Camille Hertzka will accept the award on behalf of
AStrazeneca
Vice President, Head of Medical Affairs, US Oncology at AstraZeneca
As the Medical Head of US Oncology, Camille Hertzka leads the teams responsible for the development and delivery of the medical strategy across AstraZeneca’s US oncology portfolio. She is a leading voice both within Medical Affairs and the company for inclusion and diversity efforts focused on health equity, access to care, and clinical trial participation.
A scientist by training, Camille has more than 15 years of industry experience in the oncology space both in Medical Affairs and Research & Development. She previously served as Global Product Leader for LYNPARZA, Head of Oncology Medical for Europe, and Head of Oncology Medical for International. Prior to AstraZeneca, Camille worked at BMS, leading medical affairs activities in melanoma and GU cancers for the European region. She also worked at Roche, focusing on lung cancer, brain tumors and GU cancers in France.
